AU2002210820A1 - (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine - Google Patents

(7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine

Info

Publication number
AU2002210820A1
AU2002210820A1 AU2002210820A AU1082002A AU2002210820A1 AU 2002210820 A1 AU2002210820 A1 AU 2002210820A1 AU 2002210820 A AU2002210820 A AU 2002210820A AU 1082002 A AU1082002 A AU 1082002A AU 2002210820 A1 AU2002210820 A1 AU 2002210820A1
Authority
AU
Australia
Prior art keywords
chloroisoquinolin
carboxyphenyl
guanidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210820A
Other languages
English (en)
Inventor
Michael Butters
Paul Vincent Fish
Michael Paul Fitzgerald
Julie Ann Macrae
Trevor Jack Newbury
Richard Anthony Storey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002210820A1 publication Critical patent/AU2002210820A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002210820A 2000-10-30 2001-10-16 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine Abandoned AU2002210820A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0026490.3A GB0026490D0 (en) 2000-10-30 2000-10-30 Process
GB0026490 2000-10-30
PCT/IB2001/002004 WO2002036571A1 (en) 2000-10-30 2001-10-16 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine

Publications (1)

Publication Number Publication Date
AU2002210820A1 true AU2002210820A1 (en) 2002-05-15

Family

ID=9902194

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210820A Abandoned AU2002210820A1 (en) 2000-10-30 2001-10-16 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine

Country Status (16)

Country Link
US (1) US6645979B2 (es)
EP (1) EP1330439A1 (es)
JP (1) JP2004513119A (es)
AP (1) AP2001002320A0 (es)
AU (1) AU2002210820A1 (es)
BR (1) BR0114330A (es)
CA (1) CA2427613A1 (es)
GB (1) GB0026490D0 (es)
HN (1) HN2001000246A (es)
MX (1) MXPA03003928A (es)
PA (1) PA8528801A1 (es)
PE (1) PE20020517A1 (es)
SV (1) SV2003000707A (es)
TN (1) TNSN01152A1 (es)
UY (1) UY26986A1 (es)
WO (1) WO2002036571A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015070A1 (en) * 1992-01-31 1993-08-05 Chugai Seiyaku Kabushiki Kaisha Crystal of quinolonecarboxylic acid derivative hydrate
EP1209165B1 (en) 1993-06-07 2006-04-19 Mitsui Chemicals, Inc. Propylene elastomer
GB9721964D0 (en) * 1997-10-16 1997-12-17 Pfizer Ltd Isoquinolines

Also Published As

Publication number Publication date
UY26986A1 (es) 2002-06-20
WO2002036571A1 (en) 2002-05-10
GB0026490D0 (en) 2000-12-13
JP2004513119A (ja) 2004-04-30
BR0114330A (pt) 2003-08-26
MXPA03003928A (es) 2003-08-19
PA8528801A1 (es) 2002-08-26
CA2427613A1 (en) 2002-05-10
PE20020517A1 (es) 2002-06-20
US6645979B2 (en) 2003-11-11
TNSN01152A1 (en) 2005-11-10
HN2001000246A (es) 2002-05-08
US20020077336A1 (en) 2002-06-20
SV2003000707A (es) 2003-01-13
AP2001002320A0 (en) 2001-12-31
EP1330439A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
AU2001239746A1 (en) Group-browsing system
AU2002357392A1 (en) Bag system
AU2001255300A1 (en) Multi-channel-bandwidth frequency-hopping system
AU2001253796A1 (en) Integrated auction system
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001291072A1 (en) Releasable strap
AU2001244693A1 (en) Radio
AU2000223275A1 (en) Novel triazole derivatives
AU2002212516A1 (en) Suspension system
AU2001284775A1 (en) Anti-balling system
AU2001272514A1 (en) Antenna system
AU2001246864A1 (en) Hypotensors
EP1201403A3 (en) Electrofusible units
AU2001289885A1 (en) Air-preparation system
AU2001226668A1 (en) Crankshaft-starter-generator
AU2002210820A1 (en) (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
AU2001232519A1 (en) Drawbar
AU2001278704A1 (en) Receiving system
AU2001293667A1 (en) Buckle-fastener system
AU2001258116A1 (en) Distributed discovery system
AU2001296831A1 (en) Lipocalins
AU2001277425A1 (en) Wheel
AU2002229493A1 (en) Transponder